Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for adults with attention-deficit/hyperactivity disorder
IRCT2016053028182N1Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of memantine in attention deficit hyperactivity disorder (ADHD), sponsored by Kurdistan University of Medical Sciences. Started Mar 2016; status: completed.
02
Drugs
memantine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on IRCT2016053028182N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016053028182N1.